| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |